This 2023 revision of the American Geriatric Society’s Beers Criteria for Potentially Inappropriate Medications (PIMs) in older adults includes major recommendations for the safe use of anticoagulants and for avoiding the initiation of aspirin for primary cardiovascular disease, oral and transdermal estrogens in postmenopausal women, sulfonylureas as first, second or add-on therapy for diabetes, and the use of highly anticholinergic medications. Additional areas that have been updated include how PIMs can exacerbate drug-disease and drug syndromes, important drug-drug interactions, and drugs that require alterations in dosing in renal impairment. Pharmacists should be cognizant of these changes to the AGS Beers Criteria so that they can use this tool to help optimize their older adults’ medication regimens. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.